Allelic Imbalance at 1p36 in the Pathogenesis of Human Hepatocellular Carcinoma

Hepato-Gastroenterology

Volumn 51, Issue 55, 2004, Pages 186-191

  Koshikawa, Katsumi ^a   Nomoto, Shuji ^a   Yamashita, Katsuya ^a   Ishigure, Kiyoshi ^a   Takeda, Shin ^a   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1p36; Allelic imbalance; Hepatocellular carcinoma; Tumor suppressors

Indexed keywords

ALLELIC IMBALANCE; ARTICLE; CANCER CLASSIFICATION; CHROMOSOME 1P; CLINICAL FEATURE; CONTROLLED STUDY; GENE DELETION; GENE LOCUS; GENE MAPPING; GENE TARGETING; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER RESECTION; MICROSATELLITE MARKER; MOLECULAR CLONING; POLYMORPHIC LOCUS; PRIORITY JOURNAL; TELOMERE;

ALLELIC IMBALANCE; CARCINOMA, HEPATOCELLULAR; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; HUMANS; LIVER NEOPLASMS; MICROSATELLITE REPEATS;

EID: 10744221602     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Beaseley RP, Hwang LY, Lin CC, Chien CS: Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 1981; 2:1129-1133.
2. Okuda K, Fujimoto I, Hanai A, Urano Y: Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987; 47:4962-4972.
3. Tiollais P, Pourcel C, Dejean A: The hepatitis B virus. Nature 1985; 317:489-495.
4. Sugimura T: Multistep carcinogenesis: a 1992 perspective: Science 1992; 258:603-607.
5. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Okazaki N, Takayasu K, Kosuge T, Motoo Y, Yamazaki S, Hasegawa H: Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 1990; 336:1150-1153.
6. Simon D, Carr BI: Integration of hepatitis B virus and alteration of 1p36 region found in cancerous tissue of primary hepatocellular carcinoma with viral replication evidenced only in noncancerous, chirrotic tissue. Hepatology 1995; 22:1393-1398.
7. Zimmermann U, Feneux D, Mathey G, Garyral F, Franco D, Bedossa P: Chromosomal aberrations in hepatocellular carcinoma: relationship with pathological feature: Hepatology 1997; 26:1492-1498.
8. Piao Z, Kim H, Jeon BK, Lee WJ, Park C: Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma. Cancer 1997; 80:865-872.
9. Knudson AGJr: Mutation and cancer: statistical study of retinoblastoma. Pro Natl Acad Sci USA 1971; 68:820-823.
10. Scwab M, Praml C, Amler LC: Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer 1996; 16:211-229.
11. Kusano N, Shiraishi K, Kubota K, Oga A, Okita K, Sasaki K: Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinoma: their relationship to clinicopathological features. Hepatology 1999; 29:1858-1862.
12. Simon D, Knowles BB, Weith A: Abnormalities of chromosome 1 and loss pf heterozygosity on 1p in primary hepatomas. Oncogene 1991; 6:765-770.
13. Yeh SH, Chen PJ, Chen HL, Lai MY, Wang CC, Chen DS: Frequent genetic alterations at distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res 1994; 54:4188-4192.
14. Kuroki T, Fujiwara Y, Tsuchiya E, Nakamori S, Imaoka S, Kanematsu T, Nakamura Y: Accumulation of genetic changes during development and progression of hepatocellular carcinoma. Genes Chromosomes Cancer 1995; 13:163-167.
15. Jiang GI, Liu L, Buyse IM, Simon D, Huang S: Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1. Int J Cancer 1999; 83:541-546.
16. Gregory SG, Vaudin M, Wooster R, Coleman M, Mischke D, Porter C, Schutte BC, White P, Vance JM: Report of the fourth international workshop on human chromosome 1 mapping 1998. Cytogenet Cell Genet 1998; 83:147-175.
17. White P, Forus A, Matise TC, Schutte BC, Spieker N, Stainer P, Vance JM, Gregory SG: Report of the fifth international workshop on human chromosome 1 mapping 1999. Cytogenet Cell Genet 1999; 87:143-171.
18. Tsuda H, Zhang WD, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyahara T, Hirohashi S: Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87:6791-6794.
19. Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishikawa T, Nakagama H, Harada H, Yagura M, Matsubara K, Nakamura Y: Allelotype study of primary hepatocellular carcinoma. Cancer Res 1991; 51:89-93.
20. Fujimoto Y, Hampton LL, Wirth PJ, Wang NJ, Xie JP, Thorgeirsson SS: Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinoma in China. Cancer Res 1994; 54:281-285.
21. Pineau HP, Tiollais P, Buendia MA, Dejean A: Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 1997; 14:2927-2933.
22. Tamura S, Nakamori S, Kuroki T, Sasaki Y, Furukawa H, Ishikawa O, Imaoka S, Nakamura Y: Association of cumulative allelic losses with tumor aggressiveness in hepatocellular carcinoma. J Hepatol 1997; 27:669-676.
23. Tanaka K, Yanoshita R, Konishi M, Oshimura M, Maeda Y, Mori T, Miyaki M: Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 1p36 region. Oncogene 1993; 8:2253-2258.
24. Munn KE, Walker RA, Varley JM: Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. Oncogene 1997; 10:1653-1657.
25. Tsukamoto K, Ito N, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G, Nakamura Y, Emi M: Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma. Cancer 1998; 82:317-322.
26. Bieche I, Khodja A, Lidereau R: Deletion mapping of chromosome region 1p32-pter in primary breast cancer. Genes Chromosomes Cancer 1999; 24:255-263.
27. Caron H, Sluis P, Hoeve M, Kraker J, Bras J, Slater R, Mannens M, Voute PA, Westerveld A, Versteeg R: Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat Genet 1993; 4:187-190.
28. White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, Valentine MB, Look T, Enomoto H, Sakiyama S, Brodeur GM: A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 1995; 92:5520-5524.
29. Praml C, Finke LH, Herfarth C, Schlag P, Scwab M, Amler L: Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer. Oncogene 1995; 11:1357-1362.
30. Chadwick RB, Jiang GL, Bennigton GA, Yuan B, Johnson CK, Stevens MW, Niemann TH, Peltomaki P, Huang S, Chapelle A: Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. Proc Natl Acad Sci USA 2000; 97:2662-2667.
31. Nomoto S, Haruki N, Tatematsu Y, Konishi H, Mitsudomi T, Takahashi T, Takahashi T: Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers. Genes Chromosomes Cancer 2000; 28:342-346.
32. Mori N, Morosetti R, Spira S, Lee S, Ben-Yehuda D, Schiller G, Landolfi R, Mizoguchi H, Koeffler HP: Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood 1998; 92:3405-3409.
33. Hilger W, Tang DJ, Sugar AY, Shekher MC, Hruban RH, Kern SE: High resolution deletion mapping of chromosome arm 1p in pancreatic cancer identifies a major consensus region at 1p35. Genes Chromosomes Cancer 1999; 24:351-355.
34. Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB: Localization of common deletion regions on 1p and 19q in human gliomas and their association with histrogical subtype. Oncogene 1999; 18:4144-4152.
35. Buyse IM, Takahashi E, Huang S: Physical mapping of the retinoblastoma interacting zinc finger gene RIZ to D1S228 on chromosome 1p36. Genomics 1996; 34:119-121.
36. Fang W, Piao Z, Simon D, Sheu JC, Huang S: Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ(PRDM2) gene localized to the region. Genes Chromosomes Cancer 2000; 28:269-275.
37. He L, Yu JX, Liu L, Buyse IM, Wang M, Yang M, Nakagawara A, Brodeur GM, Shi E, Huang S: RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res 1998; 58:4238-4244.
38. Wu YQ, Heilstedt HA, Bedell JA, May KM, Starkey DE, Mcpherson JD, Shapira SK, Shaffler LG: Molecular refinement of the 1p36 deletion syndrome reveals size diversity and a preponderance of maternally derived deletions. Hum Mol Genet 1999; 8:313-321.
39. Nomoto S, Haruki N, Kondo M, Konishi H, Takahashi T: Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res 1998; 58:1380-1383.
40. Mihara M, Nimura Y, Ichikawa S, Sakiyama S, Kajikawa S, Adachi W, Amano J, Nakagawara A: Absence of mutation of p73 gene at 1p36.3 in hepatocellular carcinoma. Br J Cancer 1999; 79:164-167.
41. Kemper O, Derre J, Cherif D, Engelmann H, Wallach D, Berger R: The gene for type II (p75) tumor necrosis factor receptor (TNF-RII) is localized on band 1p36.2-p36.3. Hum Genet 1991; 87:623-624.
42. Lahti JM, Valentine M, Xiang J, Jones B, Amann J, Grenet J, Richimond G, Look AT, Kidd VJ: Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neurobalstoma. Nat Genet 1994; 7:370-375.